ClinicalTrials.Veeva

Menu

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

U

University Hospital of Cologne

Status

Enrolling

Conditions

Atrial Functional Mitral Regurgitation
Mitral Insufficiency

Study type

Observational

Funder types

Other

Identifiers

NCT06911099
24-1121

Details and patient eligibility

About

This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • functional mitral regurgitation
  • left ventricular ejection fraction ≥50%

Exclusion criteria

  • age under 18 years
  • known regional wall movement disorders

Trial design

1,000 participants in 3 patient groups

Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER)
Description:
Patients who underwent mitral valve transcatheter edge-to-edge repair. All devices may be included.
Guideline Directed Medical Therapy
Description:
Patients who underwent conservative management with guideline directed medical therapy.
Transcatheter Mitral Valve Replacement (TMVR)
Description:
Patients who underwent transcatheter mitral valve replacement. All devices may be included.

Trial contacts and locations

22

Loading...

Central trial contact

Christos Iliadis, MD; Philipp von Stein, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems